HUTCHMED Announces China Approval for ORPATHYS\u00ae in Combination with TAGRISSO\u00ae for the Treatment of Lung Cancer Patient

• click to rate

  Posted by Two Blokes Jun 30 - Filed in Stock - 6 views
  
  — Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —